BABIO Influenza A/B Antigen Detection Kit Supports Fast Respiratory Virus Screening

Seasonal influenza continues to be a major concern for public health systems, healthcare facilities, diagnostic laboratories, and community screening programs worldwide. Rapid and reliable detection of influenza viruses helps improve early identification, infection management, and respiratory disease monitoring.

BABIO, a well-known Chinese manufacturer of in vitro diagnostic products, provides the Influenza A/B Antigen Detection Kit (Colloidal Gold Method), a rapid lateral flow immunochromatographic test designed for the qualitative detection of Influenza A and Influenza B antigens.

Based on advanced colloidal gold immunoassay technology, the test kit delivers clear visual results through specific antibody-antigen reactions. The dual detection design enables simultaneous screening of Influenza A and Influenza B, helping laboratories and healthcare professionals improve testing efficiency during flu seasons.

BABIO Influenza A/B Antigen Detection Kits are suitable for applications in clinical diagnostics, respiratory infection screening, healthcare institutions, and disease prevention programs. With professional manufacturing capabilities, strict quality control, and global supply experience, BABIO provides trusted rapid diagnostic solutions for customers in Europe, North America, Africa, Southeast Asia, and international markets.

For more information about BABIO rapid diagnostic products and customized solutions, please visit the official website:
https://www.babiocorp.com

#InfluenzaTest
#FluTesting
#InfluenzaAB
#RapidDiagnosticTest
#IVDTechnology
#PointOfCareTesting
#RespiratoryHealth
#VirusDetection
#HealthcareInnovation
#MedicalDiagnostics
#LaboratoryTesting
#InfectiousDiseaseTesting
#BABIO
#Biotechnology
#ChinaIVDManufacturer